:format(webp)/cdn.mskdoctors.com/storage/2026/8/eDBqkRJ5A1r3cEbE6i9pXLmSRpW9KXTA.jpg)
ACI versus MACI for Knee Cartilage RepairMACI seeds cultured cartilage cells onto a porcine-collagen scaffold fixed with fibrin glue; ACI injects them as liquid suspension sealed with a sutured flap. This mechanical difference determines recovery time, complication risk, and surgical complexity.MACI seeds cultured cartilage cells onto a porcine-collagen scaffold fixed with fibrin glue; ACI injects them as liquid suspension sealed with a sutured flap. This mechanical difference determines recovery time, complication risk, and surgical complexity.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/FEda3Z8zPavpj6fyME29Nts2lLeujPFQ.jpg)
Knee cartilage repair versus stem cell therapyEstablished cartilage repair using autologous chondrocytes shows 10–17 year durability for focal knee defects; mesenchymal stem cell therapies have not been tested in large-scale trials against them.Established cartilage repair using autologous chondrocytes shows 10–17 year durability for focal knee defects; mesenchymal stem cell therapies have not been tested in large-scale trials against them.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/766rT75vrzgAcHwc9vxAXYr5JrU3PaGe.jpg)
ChondroFiller injection versus knee replacement for focal defectsChondroFiller, a gelling collagen scaffold that recruits the patient's own cells to repair cartilage, suits isolated focal defects; knee replacement addresses widespread multi-compartment osteoarthritis.ChondroFiller, a gelling collagen scaffold that recruits the patient's own cells to repair cartilage, suits isolated focal defects; knee replacement addresses widespread multi-compartment osteoarthritis.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/JRFtBp0mcZmXZbOaQOz1rXHk9oX5RoWx.jpg)
Knee cartilage damage left untreated and when repair helpsCartilage lacks blood vessels, nerve fibres, and lymph channels, so repair cells cannot reach injuries and pain does not warn of damage, allowing lesions to expand silently until they become clinically serious.Cartilage lacks blood vessels, nerve fibres, and lymph channels, so repair cells cannot reach injuries and pain does not warn of damage, allowing lesions to expand silently until they become clinically serious.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/Xc2EYraU36Mqzzl7yRSHjrrwbnM4pNVP.jpg)
ChondroFiller™ durability compared with ArthrosamidChondroFiller™ recruits the patient's own progenitor cells to build new cartilage tissue within a collagen scaffold. Three-year published follow-up shows mean IKDC scores of 80 — a 32.4-point improvement from baseline — with durability reported to extend beyond five years.ChondroFiller™ recruits the patient's own progenitor cells to build new cartilage tissue within a collagen scaffold. Three-year published follow-up shows mean IKDC scores of 80 — a 32.4-point improvement from baseline — with durability reported to extend beyond five years.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/xTIhoJvVdRDxE765Je6PwQ1abvBdgJEl.jpg)
ChondroFiller injection cost in the UKChondroFiller injection costs £3,000–£9,800 depending on cartilage defect size; the NHS does not fund it, and quoted prices bundle assessment, imaging, injection, and six-week follow-up.ChondroFiller injection costs £3,000–£9,800 depending on cartilage defect size; the NHS does not fund it, and quoted prices bundle assessment, imaging, injection, and six-week follow-up.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/iVkAeySfTXIy2JOZ11BErGf2bexg8dSF.jpg)
ChondroFiller injection for knee cartilage defectsThe injected collagen scaffold gels in place and recruits the body's own progenitor cells to repair the cartilage defect without surgery or general anaesthetic. Functional scores improve from 48 to 80 on the IKDC scale over three years in independent European cohorts, with most of that improvement within six months.The injected collagen scaffold gels in place and recruits the body's own progenitor cells to repair the cartilage defect without surgery or general anaesthetic. Functional scores improve from 48 to 80 on the IKDC scale over three years in independent European cohorts, with most of that improvement within six months.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/1kostbLohg0wwytoKJl2x8K1M3SKeLa9.jpg)
Cartilage specialist or general orthopaedic surgeon for a knee defectKnee cartilage repair without correcting underlying malalignment results in reoperation in 47.4% of cases, versus 17.3% when alignment is corrected simultaneously — a surgical integration that general orthopaedic surgeons often omit from initial assessment and planning.Knee cartilage repair without correcting underlying malalignment results in reoperation in 47.4% of cases, versus 17.3% when alignment is corrected simultaneously — a surgical integration that general orthopaedic surgeons often omit from initial assessment and planning.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/YhFnfO9lzvEXOlGlxEL9EE2JKrJyBfB0.jpg)
ChondroFiller injection safety and the questions to askChondroFiller shows a near-zero complication rate across published trials and over 19,000 post-market cases; fibrous tissue forms only when the scaffold is overfilled, making precise dose determination from pre-procedure MRI the key safeguard.ChondroFiller shows a near-zero complication rate across published trials and over 19,000 post-market cases; fibrous tissue forms only when the scaffold is overfilled, making precise dose determination from pre-procedure MRI the key safeguard.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/K6s6v5ayT3GfYYWAcb0fIGhf69xMgqZH.jpg)
What IKDC and MOCART scores mean after ChondroFillerIKDC scores typically improve by about 30 points after ChondroFiller—roughly double the clinically meaningful threshold—translating to pain-free walking, stair management, and low-moderate recreational return within a year.IKDC scores typically improve by about 30 points after ChondroFiller—roughly double the clinically meaningful threshold—translating to pain-free walking, stair management, and low-moderate recreational return within a year.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/9Hqd2xvHBuvx5OPeQiMHYCExN1B2atBZ.jpg)
ChondroFiller injection for ankle cartilage defectsChondroFiller is an acellular collagen scaffold that fills talar cartilage defects without tissue harvest or surgery: it gels within the lesion and recruits the patient's own progenitor cells to drive repair. Delivered under ultrasound guidance as an outpatient procedure, it requires no general anaesthetic or theatre admission.ChondroFiller is an acellular collagen scaffold that fills talar cartilage defects without tissue harvest or surgery: it gels within the lesion and recruits the patient's own progenitor cells to drive repair. Delivered under ultrasound guidance as an outpatient procedure, it requires no general anaesthetic or theatre admission.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/qK5QIjTamPhwMv8E9NkiBLXaSBf3Bofl.jpg)
ChondroFiller for focal knee defects versus early osteoarthritisFocal cartilage defects and early osteoarthritis produce identical symptoms but differ structurally — a contained lesion versus compartment-wide degeneration — and imaging determines which pathway applies. ChondroFiller, an injectable collagen scaffold into which the body's progenitor cells migrate and lay down new cartilage tissue, addresses only focal lesions.Focal cartilage defects and early osteoarthritis produce identical symptoms but differ structurally — a contained lesion versus compartment-wide degeneration — and imaging determines which pathway applies. ChondroFiller, an injectable collagen scaffold into which the body's progenitor cells migrate and lay down new cartilage tissue, addresses only focal lesions.
